Skip to main content

Table 1 (abstract P220). Comparison of the 2 groups: esmolol (n=36) versus control group (n=113)

From: 39th International Symposium on Intensive Care and Emergency Medicine

 

CONTROL GROUP

ESMOLOL GROUP

p VALUE

LENGTH OF STAY (DAYS) (m. ± SE)

4.1 ± 0.6

15 ± 3

< 0.001a d

NIHSS (7 DAYS) mean (range)

2 (0 - 28)

11 (0 - 25)

< 0.001a d

COMPLICATIONNO (%)YES (%)

110 (97.3) 3 (2.7)

32 (88.9) 4 (11.1)

0.05c d

FUNCTIONAL OUTCOME(mRS ≤ 2) (%)(mRS > 2) (%)

80 (70.8) 33 (29.2)

16 (44.4) 20 (55.6)

0.004b d

SAPS II (n= 99) mean (range)

24 (6 - 59)

28 (13 - 61)

0.026a d

ATRIAL FIBRILLATIONNO (%)YES (%)

81 (71.7) 32 (28.3)

14 (38.9) 22 (61.1)

< 0.001b d

  1. a:Mann-Whitney U test. b:x2 after Yates correction. c:Fisher¢s exact test. mRS: modified Rankin Scale, NIHSS: National Institutes of Health Stroke Scale, SAPS II: Simplified Acute Physiology Score II, d:Statistically significant